Exact Mass: 433.1631

Exact Mass Matches: 433.1631

Found 57 metabolites which its exact mass value is equals to given mass value 433.1631, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(2R)-1-[4-[1,3-Benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol

(2R)-1-[4-[1,3-Benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol

C22H25F2N3O2S (433.1635)


   

4-Nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate

4-Nitrophenyl 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylic acid

C24H23N3O5 (433.1638)


   

2-Hydroxypropyl nortadalafil

2-Hydroxypropyl nortadalafil

C24H23N3O5 (433.1638)


   
   

Cys Asn Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Cys Asn Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Pro Asn Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Gln Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Ser Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Thr Asn

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Cys Gln Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Cys Gln Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Ser Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Cys Ser Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Thr Asn Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Thr Pro Asn

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Asn Cys Pro Thr

(2S,3R)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Asn Cys Thr Pro

(2S)-1-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Asn Pro Cys Thr

(2S,3R)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Asn Pro Thr Cys

(2R)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Asn Thr Cys Pro

(2S)-1-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Asn Thr Pro Cys

(2R)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Asn Thr

(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Gln Ser

(2S)-2-[(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Ser Gln

(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]butanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Thr Asn

(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]propanoic acid

C16H27N5O7S (433.1631)


   

Pro Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Pro Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Pro Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Ser Cys Gln

(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]butanoic acid

C16H27N5O7S (433.1631)


   

Pro Ser Gln Cys

(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Thr Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]propanoic acid

C16H27N5O7S (433.1631)


   

Pro Thr Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Gln Cys Pro Ser

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Gln Cys Ser Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Gln Pro Cys Ser

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Gln Pro Ser Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Gln Ser Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Gln Ser Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Ser Cys Pro Gln

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Ser Cys Gln Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Ser Pro Cys Gln

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Ser Pro Gln Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Ser Gln Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Ser Gln Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Thr Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Thr Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

JZL 195

4-Nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate

C24H23N3O5 (433.1638)


   

Lubeluzole

Lubeluzole

C22H25F2N3O2S (433.1635)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D002317 - Cardiovascular Agents D020011 - Protective Agents

   

(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate

(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate

C24H23N3O5 (433.1638)


JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively[1].

   

1-(4-(Benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol

1-(4-(Benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol

C22H25F2N3O2S (433.1635)


   

4-[2-Benzofuranyl(oxo)methyl]-1-[2-(4-morpholinyl)ethyl]-5-(3-pyridinyl)pyrrolidine-2,3-dione

4-[2-Benzofuranyl(oxo)methyl]-1-[2-(4-morpholinyl)ethyl]-5-(3-pyridinyl)pyrrolidine-2,3-dione

C24H23N3O5 (433.1638)